Bloomberg Law
April 6, 2012, 4:00 AM

Abbott Says `AbbVie’ Will Be Name
Of New Pharmaceuticals Business

Abbott Laboratories said March 21 that AbbVie will be the name of the research-based pharmaceutical company it expects to spin off by the end of 2012.

Abbott said the naming of AbbVie “is the latest milestone in the process that began in October 2011, when Abbott announced it would separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals” (5 LSLR 1005, 10/21/11).

Abbott, which is based in Abbott Park, Ill., said that AbbVie will include Abbott’s portfolio of pharmaceuticals and biologics. According to an Abbott news release, the research-based pharmaceutical ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.